Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Cytosorbents (CTSO) over the last 14 years, with Q3 2025 value amounting to 0.79.

  • Cytosorbents' Asset Utilization Ratio rose 1373.32% to 0.79 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.79, marking a year-over-year increase of 1373.32%. This contributed to the annual value of 0.71 for FY2024, which is 3260.81% up from last year.
  • According to the latest figures from Q3 2025, Cytosorbents' Asset Utilization Ratio is 0.79, which was up 1373.32% from 0.73 recorded in Q2 2025.
  • In the past 5 years, Cytosorbents' Asset Utilization Ratio ranged from a high of 0.79 in Q3 2025 and a low of 0.46 during Q3 2021
  • For the 5-year period, Cytosorbents' Asset Utilization Ratio averaged around 0.62, with its median value being 0.66 (2023).
  • Per our database at Business Quant, Cytosorbents' Asset Utilization Ratio plummeted by 3918.0% in 2021 and then surged by 3711.41% in 2023.
  • Cytosorbents' Asset Utilization Ratio (Quarter) stood at 0.47 in 2021, then increased by 18.2% to 0.55 in 2022, then skyrocketed by 30.81% to 0.72 in 2023, then rose by 3.43% to 0.75 in 2024, then rose by 5.48% to 0.79 in 2025.
  • Its Asset Utilization Ratio stands at 0.79 for Q3 2025, versus 0.73 for Q2 2025 and 0.72 for Q1 2025.